Validation Report

#029581

Chromosome 19 Open Reading Frame 80 (C19ORF80) ELISA Kit (ABIN1136417) has been independently validated for ELISA by the Science Exchange network of experts.

The Science Exchange network is used to independently validate research reagents, protocols, and results to ensure accuracy and reproducibility.

Validation number: #029581

Validated on: 01/26/14

Summary

Antigen

Human Chromosome 19 Open Reading Frame 80 (C19ORF80)

Catalog number

Supplier

EIAab

Supplier catalog number

Lot number

3L306L

Method validated

Laboratory

Validation number

Positive Control

Human serum

Negative Control

Mouse serum

Notes

Matrix interference indicates that serum must be diluted >10 fold for accurate measurement. Kit returned minor signal for negative control sample.

Independent Results

Full Methods

Primary Antibody
  • Antigen: Human Chromosome 19 Open Reading Frame 80 (C19ORF80)
  • Catalog number: E11644h
  • Supplier: EIAAB Science Co.
  • Lot number: 3L306L
Controls
  • Positive control: normal human serum
  • Negative control: mouse serum
  • Standard curve: serial two-fold dilutions from 5000 pg/ml (5000, 2500, 1250, 625, 312.5, 156.25, 78.125, 0) were generated from the standard provided in the kit using sample diluent buffer.
  • Spike control: standard diluted in human or mouse serum (500 pg/mL).
Protocol
  • All reagents in the ELISA kit were brought up to room temperature (RT) before use.
  • 100 µl of each sample was added per well to the micro ELISA plate well. All samples and standards were assayed in triplicate.
  • The plate was covered with sealer (provided in kit) and incubated for 120 mins at 37°C.
  • Liquid was removed from each well by pipette.
  • Detection Reagent A was diluted 100 fold in Assay Diluent A. 100 µl of diluted detection reagent A was added to each well and the plate was sealed. The plate was tapped to ensure mixing and incubated for 60 mins at 37°C.
  • Wells were washed with 300 µl wash buffer three times. Each wash involved fully aspirating the liquid from each well by pipette. After the last wash the plate was inverted against clean absorbent paper to remove any remaining liquid.
  • Detection Reagent B was diluted 100 fold in Assay Diluent B. 100 µl of diluted detection reagent B was added to each well and the plate was sealed. The plate was tapped to ensure mixing and incubated for 60 mins at 37°C.
  • Wells were washed with 300 µl wash buffer five times. Each wash involved fully aspirating the liquid from each well by pipette. After the last wash the plate was inverted against clean absorbent paper to remove any remaining liquid.
  • 90 µl of Substrate Solution was added to each well and the plate was covered with a new plate sealer. The plate was tapped to ensure mixing and incubated at room temperature in the dark.
  • After about 10 mins, when an apparent gradient appeared in the standard wells, the reaction was terminated by adding 50 µl of Stop Solution to each well.
  • The optical density (OD value) of each well was read using a micro-plate reader set to 450 nm.
  • The triplicate readings for each sample were averaged and the average zero standard optical density subtracted. A standard curve was generated by plotting the mean OD value for each standard on the y-axis against the concentration on the x-axis using Softmax Pro softare.
  • The equation y = (A-D)/(1 + (x/C)^B) + D was used to calculate IL-6 concentrations of the samples based on their average OD values.
Experimental Notes

Percent recovery of the spiked samples shows that there is matrix interference. Dilution of >10 fold is required for accurate measurement of the analyte in human serum samples.

Figures

1393469893836 de4ad1a243080dd25d2c38fc8550e0f0.png?fit=fill&mark=%2freproducibility%2ftsen logo

Figure 1: Graph of corrected-average absorbance (OD 450 nm) readings plotted for standard curve samples.

1393469893846 6386311f65734dbda558ef06bcbd390e.png?fit=fill&mark=%2freproducibility%2ftsen logo

Table 1: ELISA. C19ORF80 could be detected in human serum (positive control). Spike controls indicate that there is interference from the human serum matrix and a dilution of >10 fold is required. Mouse serum was used as negative control, there were residual levels of C19ORF80.

1393469893850 946b0df4add90b1a4ab40e8a35cf83f3.png?fit=fill&mark=%2freproducibility%2ftsen logo

Table 2: Table of absorbance readings (OD 450 nm) for standard curve. Value for Average Reading is derived from the average of three readings (OD 450nm). The Average Reading for BLANK (0 pg/ml) was subtracted from all Average Readings to yield Average Absorbance values for Standards. Standard deviation is included for all samples. An equation (see Figure 1) was generated from the standard curve and used to calculate C19ORF80 concentrations shown in Table 1.